AGC Biologics is a leading global CDMO providing contract development and manufacturing services for biologics, cell and gene therapies, and advanced modalities. With facilities in Seattle, Copenhagen, Heidelberg, Milan, Chiba, and Yokohama, AGC operates mammalian and microbial expression systems and offers end-to-end services from process development through commercial-scale manufacturing.
Mammalian cell culture, microbial fermentation, cell and gene therapy, viral vectors, mRNA, monoclonal antibodies, ADCs, plasmid DNA, process development
6 sites worldwide
No reviews available yet.
No documents available.